Lucas Energy, Inc. (AMEX: LEI), an independent oil and gas company, has focused its efforts on building a diversified portfolio of valuable oil and gas assets in the United States. The company is focused on identifying underperforming oil and gas … Continue reading →

Alseres Pharmaceuticals, Inc. (NASDAQ: ALSE) is focused on developing therapeutic and diagnostic products designed mainly for disorders in the central nervous system. The company’s robust molecular imaging development program targets the diagnosis of Parkinson’s disease and potentially dementia. Altropane, the … Continue reading →

Alphatec Spine, Inc. (NASDAQ: ATEC), a wholly owned subsidiary of Alphatec Holdings, Inc. (Nasdaq:ATEC), is focused on designing, developing, manufacturing and marketing products for the surgical treatment of spine disorders. The company aims to combine world-class customer service with innovative, … Continue reading →

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a biopharmaceutical company, is focused on developing novel therapeutics based on RNA interference, or RNAi. By applying its therapeutic expertise in RNAi, the company intends to address substantial medical needs, many of which cannot be … Continue reading →

Lorus Therapeutics, Inc. (AMEX: LRP), a biopharmaceutical company, is focused on discovering, researching and developing effective anticancer therapies with high safety profiles. By utilizing its own discovery efforts, in addition to acquisition and in-licensing programs, the company is building a … Continue reading →

LightPath Technologies, Inc. (NASDAQ: LPTH) is a recognized leader in optical solutions for industrial, defense, communications, test and measurement, and medical applications. With unique products such as Black Diamond Infrared Lenses and Gradium Lenses, LightPath Technologies is shedding light in … Continue reading →

Allos Therapeutics, Inc. (NASDAQ: ALTH), a biopharmaceutical company, is committed to developing and commercializing innovative small molecule drugs for the treatment of cancer. Pralatrexate (PDX), the Company’s lead product candidate, is a novel antifolate currently in a pivotal Phase 2 … Continue reading →

LCA-Vision, Inc. (NASDAQ: LCAV) provides laser vision correction services under its well known Lasik Plus brand. The company currently owns and operates over 70 LasikPlus fixed-site laser vision correction centers in the United States and a joint venture in Canada. … Continue reading →

La Jolla Pharmaceutical Company (NASDAQ: LJPC) is focused on improving and preserving human life through the development of novel pharmaceutical products. Riquent®, the company’s leading product in development, treats lupus renal disease, a leading cause of sickness and death in … Continue reading →

AgFeed Industries, Inc. (NASDAQ: FEED), the largest commercial hog producer and the largest premix feed company in China, owns and operates 28 commercial hog farms with annual production of more than 650,000 hogs and five premix feed plants. The company’s … Continue reading →